AOD-9604 is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications
Other benefits of MOTS-c MOTS-cs diverse therapeutic effects may help users realize numerous downstream health effects: Diabetes: Inefficient glucose uptake is a characteristic of type 2 diabetes, and mitochondrial dysfunction may result in two risk factors for the disease insulin resistance and impaired insulin secretion.32 33 MOTS-cs actions on these risk factors may help nip them in the bud.34 Cardiovascular health: Diabetes is a cardiovascular risk factor, so cutting it from the picture can spell significant improvements in heart health.35 A high body-fat percentage is another such risk factor, so if MOTS-c can prevent obesity, it can halt the onset of a health condition characteristic of more than 80% of people with coronary heart disease.36 37 Longevity: Given the link between inflammation, age, and high-risk age-related diseases (e.g., atherosclerosis, cardiovascular disease), MOTS-c may increase lifespan as a continual downstream effect.38 Cognitive function: A 2022 review published in Progress in Neurobiology noted that metabolic modulators (which MOTS-c is) and exercise (which MOTS-c simulates) can be used in neuroprotective strategies.39 Or at least that has been the case in preclinical studies
MPLfcinB6 created by linking 7 arginines to LfcinB via glycine-glycine binding sites, effectively eliminates human T-leukaemia cells with an IC50 value of 25 M, which is half of what it was before modification (35,36)
The "before and after" efficacy narrative drives significant demand, shaping key industry movements
Off-label protocols typically range from 2 to 10 mcg per kilogram of body weight per day
In contrast, GHK-Cu administered subcutaneously is released into the bloodstream instantly and in a controlled dose, which triggers more than 300 repair-related genes, helps to multiply fibroblast growth and contributes to the longevity of epidermal stem cells located in the basal layer
